Quantcast

Latest Pharmaceutical drug Stories

2014-08-28 12:29:50

Ribbon-Cutting Ceremony Scheduled for September 3, 2014 ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, will hold a ribbon-cutting ceremony on September 3, 2014, in Tasly's corporate offices in Rockville, MD. The ceremony will mark the official launch of Tasly Pharmaceuticals, Inc. as the North American headquarters of Tasly Holding Group, a global technology company established in China...

2014-08-26 12:30:12

DALLAS, August 26, 2014 /PRNewswire/ -- According to the new research report "Scale Inhibitor Market by Type (Phosphonates, Carboxylate/Acrylic, Sulfonates and Others), and by Application (Power & Construction, Mining, Oil & Gas, Water & Waste Water Treatment, Food & Beverage and Others) - Global Trends & Forecast to 2019", defines and segments the global scale inhibitor market with an analysis and forecast for types and applications by volume as well...

2014-08-24 23:00:47

Over the five-year period, many thin film drug manufacturers will focus on developing a drug pipeline that encompasses more therapeutic classes, such as drugs that treat respiratory-related ailments. For these reasons, industry research firm IBISWorld has updated a report on the Thin Film Drug Manufacturing industry in its growing industry report collection. New York, NY (PRWEB) August 24, 2014 Over the past five years, the Thin Film Drug Manufacturing industry has exhibited rapid revenue...

2014-08-22 23:02:33

Transparency Market Research added a new report "Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Albany, New York (PRWEB) August 22, 2014 Ophthalmic drug delivery technologies or mechanisms represent one of the interesting and challenging endeavors as the anatomy, physiology and biochemistry of the eye renders highly impervious properties to the foreign substances. Ocular drug delivery...

2014-08-20 16:25:21

LONDON, Aug. 20, 2014 /PRNewswire/ -- GlaxoSmithKline plc today announced that the FDA has approved Arnuity(TM) Ellipta(®) (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. Arnuity is not indicated for relief of acute bronchospasm. The approved doses are Arnuity Ellipta 100mcg and 200mcg. Arnuity Ellipta is administered once daily via the dry...

2014-08-18 23:05:04

MarketReportsOnline.com adds "Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)" report to its research store. Dallas, Texas (PRWEB) August 18, 2014 The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and Allylamines. It provides broad coverage of these classes...

2014-08-18 16:25:21

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Local Anesthetic Effect-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278631/-Local-Anesthetic-Effect-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," Local Anesthetic Effect-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline...

2014-08-14 16:27:42

Pharmacy benefit manager misleading patients, advocates say FAIRHOPE, Ala., Aug. 14, 2014 /PRNewswire/ -- Express Scripts, the nation's largest pharmacy benefit manager, is offering ambiguous and misleading reasons for ending coverage of customized prescription medications for 540,000 individuals in order to conceal financial motives, a Patients and Physicians for Rx Access said Thursday, Aug. 14. The organization is fighting to stop the unprecedented benefit cuts being made by...

2014-08-12 23:10:34

A Rise In Lipitor Lawsuit Claims Jumped In Five Months With Filings That Contend Development Of Type 2 Diabetes After Taking The Cholesterol Lowing Medication, Notes Wright & Schulte LLC Columbus, OH (PRWEB) August 12, 2014 The harmful drug attorneys at Wright & Schulte LLC have learned through a Reuters analysis that Lipitor diabetes lawsuits filed against Pfizer Inc. have spiked over the past five months primarily due to all federally filed Lipitor lawsuit claims consolidated in...

2014-08-12 23:02:26

The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. New York, New York (PRWEB) August 12, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that claim the popular statin medication caused patients to develop Type 2 diabetes continue to mount in a federal multidistrict litigation underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports....


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related